Sudeep Pharma Ltd. (MAINBOARD)

IPO Details

Key Performance Indicator (KPI)

Company Financial (In ₹Crore)

COMPARISON WITH INDUSTRY PEERS

*Company does not have any peer group company for comparison with Industry Peer.

About Company

Incorporated in 1989, Sudeep Pharma Limited is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, supplying to 100+ countries.

The company operates six manufacturing facilities with a total capacity of 50,000 MT, producing a wide range of mineral-based ingredients including calcium, iron, magnesium, zinc, potassium, and sodium.

Sudeep Pharma offers 200+ products to customers across pharma, food, and nutrition industries, supported by robust in-house R&D and pilot-scale facilities specialising in excipients and mineral salts.

Its product portfolio includes:

Pharmaceutical, Food & Nutrition Business

Specialty Ingredients Business

Triturates

As of December 31, 2024, the company had 704 permanent employees.

Strength

Market Leadership with a Diversified Portfolio: The company is a leading manufacturer of pharmaceutical, food, nutrition, and specialty ingredients (as of June 30, 2025), with strong positioning in mineral-based products and iron phosphate, along with a wide range of specialty food ingredients like encapsulated preservatives.

Robust and Compliant Manufacturing Infrastructure: The company operates four manufacturing facilities with 12 production lines across Gujarat and Ireland, spanning 68,446 sq. meters and offering an annual capacity of 72,246 MT, ensuring strong compliance and efficient production capabilities.

Strong R&D Capabilities Driving Innovation: With two R&D facilities and a dedicated team of 41 professionals, the company focuses on particle engineering, improving shelf life, nutrient bioavailability, and formulation solutions, supported by advanced equipment to enhance technology, sustainability, and product expansion.

Weakness

High Revenue Dependence on Limited Customers: A significant portion of revenue comes from a small number of customers, and losing any of them or facing reduced demand could negatively impact business, financial performance, and cash flows.

Regulatory and Quality Compliance Risks: The company’s manufacturing facilities undergo regular inspections and must comply with strict standards set by global agencies like USFDA, EXCiPACT, FSSC, WHO-GMP, ISO, and HACCP. Any quality issues or non-compliance could result in regulatory action and reputational damage.

Operational Disruption Risks: Manufacturing and R&D operations are exposed to risks such as equipment failure, industrial accidents, regulatory non-compliance, natural disasters, and infectious disease outbreaks. Any slowdown or shutdown could adversely affect business, results, and cash flows.